Format

Send to

Choose Destination
Eur J Med Res. 2000 Apr 19;5(4):171-5.

Proof of efficacy of Kamillosan(R) cream in atopic eczema.

Author information

1
ASTA Medica AG, Weismüllerstr. 45, D-60314 Frankfurt am Main, Germany. Dr_Jeannette.Simon@astamedica.de

Abstract

Kamillosan(R) cream contains chamomile extract as active principle manufactured from the chamomile sort Manzana which is rich in active principles and has been proved not to exhibit a chamomile-related allergen potential. For this reason Kamillosan(R) cream is suited for local therapy of atopic eczema. In a partially double-blind, randomized study carried out as a half-side comparison, Kamillosan(R) cream was tested vs. 0.5% hydrocortisone cream and the vehicle cream as placebo in patients suffering from medium-degree atopic eczema. After a 2-week treatment Kamillosan(R) cream showed a mild superiority towards 0.5% hydrocortisone and a marginal difference as compared to placebo.

PMID:
10799352
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center